| AF | atrial fibrillation |
| ARBs | angiotensin receptor blockers |
| ASA | aspirin |
| BMS | bare metal stent |
| BNP | brain natriuretic peptide |
| CA | coronary angiography |
| CABG | coronary artery bypass grafting |
| CAD | coronary artery disease |
| CCTA | coronary computed tomographic angiography |
| CMRI | cardiac magnetic resonance imaging |
| COVID-19 | 2019 Coronavirus disease |
| ClCr | creatinine clearance |
| CT | computed tomography |
| DAPT | dual antiplatelet therapy |
| DES | drug eluting stent |
| ECG | electrocardiogram |
| FoCUS | focused cardiac ultrasound study |
| GFR | glomerular filtration rate |
| GPIIb-IIIa | glycoprotein IIb/IIIa inhibitors |
| HF | heart failure |
| INR | international normalized ratio |
| LMWH | low molecular weight heparin |
| MACEs | major adverse cardiac events |
| METs | metabolic equivalents |
| MI | myocardial infarction |
| NOACs | non-vitamin K antagonist oral anticoagulants |
| NSQIP | National Surgical Quality Improvement Program |
| NT-proBNP | N-terminal-pro hormone BNP |
| PCI | percutaneous coronary intervention |
| RCRI | Revised Cardiac Risk Index |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus-2 |
| SPECT | single-photon emission computed tomography |
| TTE | transthoracic color-Doppler echocardiography |
| TURP | transurethral resection of the prostate |
| UFH | unfractionated heparin |
| VKAs | vitamin K antagonists |